Cargando…
Azilsartan Modulates HMGB1/NF-κB/p38/ERK1/2/JNK and Apoptosis Pathways during Renal Ischemia Reperfusion Injury
Renal ischemia/reperfusion (IR) injury is characterized by an unexpected impairment of blood flow to the kidney. Azilsartan is an angiotensin receptor blocker that is approved for the management of hypertension. The present study aimed to investigate, on molecular basics, the nephroprotective activi...
Autores principales: | Alaaeldin, Rania, Bakkar, Sally M., Mohyeldin, Reham H., Ali, Fares E. M., Abdel-Maqsoud, Nehad M. Reda, Fathy, Moustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818604/ https://www.ncbi.nlm.nih.gov/pubmed/36611978 http://dx.doi.org/10.3390/cells12010185 |
Ejemplares similares
-
Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan
por: Alaaeldin, Rania, et al.
Publicado: (2022) -
Pantoprazole Attenuates MAPK (ERK1/2, JNK, p38)–NF-κB and Apoptosis Signaling Pathways after Renal Ischemia/Reperfusion Injury in Rats
por: Fawzy, Michael A., et al.
Publicado: (2021) -
Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway
por: Alaaeldin, Rania, et al.
Publicado: (2023) -
JNK, p38, ERK, and SGK1 Inhibitors in Cancer
por: Cicenas, Jonas, et al.
Publicado: (2017) -
A New EGFR Inhibitor from Ficus benghalensis Exerted Potential Anti-Inflammatory Activity via Akt/PI3K Pathway Inhibition
por: Alaaeldin, Rania, et al.
Publicado: (2022)